MOMEN ELNESR: Open Payments
NPI 1316981780 · WORCESTER, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,158 in 111 payments from 11 companies in 2025. Trend: 2023 $1,633 · 2024 $1,684 · 2025 $2,158
Food & beverage: $2,005Education: $153
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 31 | $388 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 16 | $377 |
| Alkermes, Inc. | 15 | $356 |
| ABBVIE INC. | 10 | $237 |
| E.R. Squibb & Sons, L.L.C. | 7 | $210 |
| Lundbeck LLC | 8 | $198 |
| Otsuka America Pharmaceutical, Inc. | 15 | $175 |
| Janssen Pharmaceuticals, Inc | 3 | $93 |
| Orexo US, Inc. | 3 | $54 |
| Axsome Therapeutics, Inc. | 2 | $48 |
Products named: FANAPT, CAPLYTA, REXULTI, VRAYLAR, COBENFY, ARISTADA, VIVITROL, SPRAVATO.
Industry payments across MA — which companies pay providers there.
